Trials / Completed
CompletedNCT06069921
Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
Ultrasound-based Deep Learning Signature and Radiomics Signature Nomogram for Diagnosis of Benign and Malignant Breast Lesions of BI-RADS Category 4 Using Intratumoral and Peritumoral Regions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Ma Zhe · Academic / Other
- Sex
- Female
- Age
- 15 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to diagnose benign and malignant breast lesions with BI-RADS 4 classification. Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.
Conditions
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2022-12-30
- Completion
- 2022-12-30
- First posted
- 2023-10-06
- Last updated
- 2024-06-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06069921. Inclusion in this directory is not an endorsement.